What MECTA LTD does

MECTA LTD, operating legally as MECTA LLC (formerly MECTA Corporation), is a privately held US medical device manufacturer specializing in electroconvulsive therapy (ECT) equipment. Founded as a trade name in continuous operation since 1938 and headquartered in the Portland, Oregon area, the company designs and produces the FDA-approved MECTA spECTrum and MECTA Σigma ECT devices, which deliver controlled electrical pulses to induce therapeutic seizures for patients with severe, treatment-resistant psychiatric conditions including major depression, bipolar disorder, and psychotic illnesses such as schizophrenia. The core product line includes both 100 Joule (DOM) and 200 Joule (INT) device configurations, along with optional accessories, replacement parts, and post-sale technical service.

The company sells exclusively to licensed health providers and hospitals — it does not sell to or interact directly with patients. In the United States and Canada, MECTA operates a direct sales model with phone-based customer service during Pacific Standard Time business hours; internationally, it routes customers through a network of local distributor representatives. Revenue is generated through hardware sales (devices and accessories), recurring service and technical support contracts, and ancillary educational offerings including the International Course on Electroconvulsive Therapy, clinician training programs, fellowships, and the Patients & Families Information Booklet bundled with each device. The company maintains a modest direct footprint and relies on academic and clinical partners — including Dartmouth-Hitchcock Medical Center, Sutter Health, Resnick Neuropsychiatric Hospital, and Menninger Clinic — for educational content and clinical training support.

Name

MECTA LTD

Legal name

MECTA LLC

Website

https://mectaspectrum.com

Company type

Private

Founded year

1980

Operating status

Operating

Short description

MECTA LTD (legal entity MECTA LLC) manufactures FDA-approved electroconvulsive therapy devices — the MECTA spECTrum and MECTA Σigma — for treatment-resistant psychiatric conditions, selling exclusively to licensed health providers and hospitals via direct US/Canada sales and international distributors.

Ownership category

akta.pro rank

Product category

Psychiatric Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL)

Keywords

• Electroconvulsive therapy devices
• Psychiatric medical devices
• ECT device manufacturing
• Clinical ECT training
• Medical device service

Headquarters

HQ city

Portland area (inferred)

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. ECT Device Sales: MECTA manufactures and sells ECT devices to licensed healthcare providers and hospitals. The company also provides service and technical support for their devices.
2. Device Accessories and Parts: Sale of optional accessories for the MECTA spECTrum device. Part numbers referenced include DOM (100 Joule): 9900-1021 and INT (200 Joule): 9900-1018.
3. Service and Technical Support: Post-sale technical assistance, diagnostic services, and support for device owners.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

MECTA manufactures and sells FDA-approved electroconvulsive therapy (ECT) devices, including the MECTA spECTrum and MECTA Σigma systems, along with optional accessories and clinician training resources. The company sells exclusively to licensed health providers and hospitals for the treatment of severe psychiatric disorders such as major depression, bipolar disorder, and psychotic illnesses. Post-sale technical service and international distribution are provided through a combination of direct U.S./Canada support and a network of international distributor representatives.

Product overview

MECTA LTD is a medical device manufacturer that produces electroconvulsive therapy (ECT) devices for psychiatric treatment. The company's core product line includes the MECTA spECTrum device and MECTA Σigma device, sold to licensed health providers and hospitals. The product portfolio also includes optional accessories, the Patients & Families Information Booklet (included with device purchase), and professional training programs including the International Course on ECT. The company provides device service and technical support through its Service program.

Differentiator

Problem solved

Functional benefit

Brands

• MECTA Σigma: ECT device product line

Products and services

• MECTA spECTrum ECT Device FDA-approved electroconvulsive therapy (ECT) device used by licensed healthcare providers and hospitals to deliver controlled electrical pulses that induce therapeutic seizures for treatment-resistant major depression, bipolar disorder, and psychotic illnesses such as schizophrenia.
• MECTA spECTrum Optional Accessories Optional accessories and components used to support the operation of the MECTA spECTrum ECT device in clinical settings.
• MECTA Σigma ECT Device ECT device model available in DOM (100 Joule) and INT (200 Joule) configurations for clinical use by licensed healthcare providers.
• MECTA Service and Technical Support Post-sale technical support, diagnostics, and service for MECTA ECT device owners, delivered directly in the U.S. and Canada and through international distributor representatives elsewhere.
• ECT Training Programs and Fellowships Clinical training programs and fellowships covering ECT procedures and best practices, offered to clinicians administering or supporting ECT in licensed facilities.
• International Course on Electroconvulsive Therapy Professional educational course covering ECT practices and clinical applications, targeted at international clinicians involved in ECT administration.
• Patients and Families Information Booklet Educational booklet covering who should receive ECT, how it works, effects on thinking and memory, and physical risks; provided with every MECTA device purchase and available for separate purchase to inform patients and families.

Quantifiable outcome

• ECT associated with 50 percent reduction in risk for suicide among patients with depression in the year after hospitalization (CAMH and ICES study of over 67,000 patients)
• +1 more outcomes

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core and minor.

• International Distributor RepresentativescoreChannel Partner/ Reseller/ DistributorMECTA has a network of international distributor representatives who provide service support, technical assistance, and distribution of MECTA ECT devices in countries outside the U.S. and Canada.
• Dartmouth-Hitchcock Medical CenterminorStrategic or Co-development PartnerProduced an educational ECT DVD under exclusive distribution from MECTA Corporation. This partnership provides educational content about electroconvulsive therapy for patient and clinician education.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• LivaNova: Public neuromodulation and cardiac device company whose vagus nerve stimulation (VNS) therapy is FDA-approved for treatment-resistant depression. A broader incumbent that competes with ECT in the refractory depression segment via an implantable modality.

Emerging players

• Flow Neuroscience: European maker of an at-home transcranial direct current stimulation (tDCS) device marketed for depression. Targets the same patient segment as ECT with a non-clinical, lower-stigma delivery model.
• Brainsway: Developer of deep transcranial magnetic stimulation (Deep TMS) systems cleared by the FDA for major depressive disorder and OCD. A direct alternative modality to ECT for the same treatment-resistant population MECTA addresses.
• Neuronetics: Commercial-stage developer of the NeuroStar TMS system, FDA-cleared for treatment-resistant depression. Competes with MECTA for the same psychiatric patient population via a less-stigmatized, non-convulsive modality.
• Apollo Neuroscience: Consumer wearable neurostimulation device maker focused on stress, sleep and anxiety. Operates in the same underlying neurostimulation technology category as MECTA but positioned for consumer mental wellness rather than clinical psychiatric care.
• Fisher Wallace: Manufacturer of a consumer-grade cranial electrotherapy stimulation (CES) device for depression, anxiety and insomnia. Overlaps with MECTA's neurostimulation category but in a consumer/prescription-adjacent positioning.

Direct peers

• Somatics LLC: Manufacturer of the Thymatron, the leading direct competitor to MECTA's spECTrum ECT device. Both companies sell FDA-cleared electroconvulsive therapy devices to hospitals and psychiatric clinics for treatment-resistant depression and severe psychiatric conditions.
• Magstim: UK-based manufacturer of neurostimulation devices spanning ECT and transcranial magnetic stimulation (TMS). Directly comparable as a clinical-grade electrotherapeutic apparatus maker targeting the same psychiatric and neuroscience end-markets as MECTA.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MECTA LTD